.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The LACC randomized trial compared minimally invasive radical hysterectomy with open abdominal radical hysterectomy in women with early-stage cervical cancer. Minimally invasive surgery was associated with lower disease-free and overall survival than open surgery in the trial population, leading to major changes in surgical practice. The finding is crucial for gynecologic oncology because it demonstrates that better perioperative recovery does not automatically translate into equivalent oncologic outcomes. For clinicians, route of surgery must therefore be evaluated in terms of cancer control, not only blood loss and length of stay. Patient counseling should explain the evidence, while tumor characteristics, surgical expertise and evolving guideline recommendations inform the final decision. The trial is a cornerstone example of why randomized evidence matters when new technology enters cancer surgery.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The LACC randomized trial compared minimally invasive radical hysterectomy with open abdominal radical hysterectomy in women with early-stage cervical cancer. Minimally invasive surgery was associated with lower disease-free and overall survival than open surgery in the trial population, leading to major changes in surgical practice. The finding is crucial for gynecologic oncology because it demonstrates that better perioperative recovery does not automatically translate into equivalent oncologic outcomes. For clinicians, route of surgery must therefore be evaluated in terms of cancer control, not only blood loss and length of stay. Patient counseling should explain the evidence, while tumor characteristics, surgical expertise and evolving guideline recommendations inform the final decision. The trial is a cornerstone example of why randomized evidence matters when new technology enters cancer surgery.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
